Alector (ALEC) Competitors

CorMedix (NASDAQ:CRMD) and Alector (NASDAQ:ALEC) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends, media sentiment, community ranking and earnings.

Which has more risk and volatility, CRMD or ALEC?

CorMedix has a beta of 1.57, suggesting that its share price is 57% more volatile than the S&P 500. Comparatively, Alector has a beta of 0.73, suggesting that its share price is 27% less volatile than the S&P 500.

Do analysts prefer CRMD or ALEC?

CorMedix presently has a consensus price target of $14.50, suggesting a potential upside of 95.95%. Alector has a consensus price target of $3.50, suggesting a potential upside of 224.07%. Given Alector's higher probable upside, analysts plainly believe Alector is more favorable than CorMedix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CorMedix	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	3.14
Alector	2 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.14

Which has higher earnings and valuation, CRMD or ALEC?

CorMedix has higher earnings, but lower revenue than Alector. CorMedix is trading at a lower price-to-earnings ratio than Alector, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CorMedix	$43.47M	11.10	-$46.34M	-$0.33	-22.42
Alector	$100.56M	1.06	-$130.39M	-$1.23	-0.88

Do insiders and institutionals hold more shares of CRMD or ALEC?

34.2% of CorMedix shares are held by institutional investors. Comparatively, 85.8% of Alector shares are held by institutional investors. 5.2% of CorMedix shares are held by insiders. Comparatively, 9.1% of Alector shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Does the MarketBeat Community prefer CRMD or ALEC?

Alector received 123 more outperform votes than CorMedix when rated by MarketBeat users. However, 78.57% of users gave CorMedix an outperform vote while only 60.94% of users gave Alector an outperform vote.

Company	Underperform	Outperform
CorMedix	Outperform Votes 33 78.57%	Underperform Votes 9 21.43%
Alector	Outperform Votes 156 60.94%	Underperform Votes 100 39.06%

Is CRMD or ALEC more profitable?

CorMedix has a net margin of 0.00% compared to Alector's net margin of -257.54%. CorMedix's return on equity of -79.21% beat Alector's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CorMedix	N/A	-79.21%	-64.68%
Alector	-257.54%	-108.77%	-27.03%

Does the media prefer CRMD or ALEC?

In the previous week, CorMedix had 3 more articles in the media than Alector. MarketBeat recorded 5 mentions for CorMedix and 2 mentions for Alector. Alector's average media sentiment score of 0.93 beat CorMedix's score of 0.49 indicating that Alector is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CorMedix	1 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Alector	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

CorMedix beats Alector on 11 of the 19 factors compared between the two stocks.